Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy BioLineRx (BLRX) stocks in Canada
Learn how to easily invest in BioLineRx stocks.
BioLineRx is a biotechnology business based in the US. BioLineRx stocks (BLRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.29 – a decrease of 4.23% over the previous week. BioLineRx employs 38 staff and has a market cap (total outstanding stock value) of $89.2 million.
How to buy shares in BioLineRx
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BLRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in BioLineRx?
- Has coronavirus impacted BioLineRx shares?
- BioLineRx shares summary
- Compare share dealing platforms
- Is BioLineRx stock a buy or sell?
- BioLineRx performance over time
- Are BioLineRx shares over-valued?
- BioLineRx's financials
- How volatile are BioLineRx shares?
- Does BioLineRx pay a dividend?
- Have BioLineRx shares ever split?
- Other common questions
BioLineRx stock price (NASDAQ:BLRX)Use our graph to track the performance of BLRX stocks over time.
BioLineRx shares at a glance
|Latest market close||$1.81|
|52-week range||$1.70 - $6.34|
|50-day moving average||$2.31|
|200-day moving average||$2.77|
|Wall St. target price||$14.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.93|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy BioLineRx stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
BioLineRx price performance over time
|1 week (2022-01-20)||-4.23%|
|1 month (2021-12-28)||-15.42%|
|3 months (2021-10-28)||-36.93%|
|6 months (2021-07-28)||-44.82%|
|1 year (2021-01-28)||-38.23%|
|2 years (2020-01-27)||-24.58%|
|3 years (2019-01-25)||199.27%|
|5 years (2017-01-27)||69.16%|
Is BioLineRx under- or over-valued?
Valuing BioLineRx stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioLineRx's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
BioLineRx's PEG ratio
BioLineRx's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.2. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioLineRx's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Gross profit TTM||$0|
|Return on assets TTM||-22.61%|
|Return on equity TTM||-72.59%|
|Market capitalisation||$89.2 million|
TTM: trailing 12 months
BioLineRx share dividends
We're not expecting BioLineRx to pay a dividend over the next 12 months.
Have BioLineRx's shares ever split?
BioLineRx's shares were split on a 1:15 basis on 14 July 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioLineRx shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for BioLineRx shares which in turn could have impacted BioLineRx's share price.
BioLineRx share price volatility
Over the last 12 months, BioLineRx's shares have ranged in value from as little as $1.7 up to $6.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioLineRx's is 1.4642. This would suggest that BioLineRx's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
BioLineRx Ltd. , a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of solid tumors, hematological malignancies, and stem cell mobilization; AGI-134, an immuno-oncology agent in the development for solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The company has collaboration agreement with MSD for the cancer immunotherapy field; MD Anderson Cancer Center to investigate the combination of BL-8040 with KEYTRUDA (pembrolizumab) in pancreatic cancer; and Genentech Inc. to investigate the combination of BL-8040 for solid tumors. BioLineRx Ltd. was founded in 2003 and is headquartered in Hevel Modi'in, Israel.
BioLineRx in the news
BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine, AGI-134, in Unresectable Metastatic Solid Tumors
What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020
Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.